EAST WINDSOR, N.J.--(BUSINESS WIRE)--NexMed, Inc. (NASDAQ: NEXM), a developer of innovative transdermal treatments based on the NexACT® drug delivery technology, today announced that the Company has been added to the Russell Microcap® Index, after Russell Investment Group reconstituted its comprehensive set of U.S. and global equity indexes on June 22, 2007.
